NEWS MORE

• REVIVING HERITAGE: REBIRTH OF A LEGACY
• Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

• The Block Appoints Steve Chung as CEO to Accelerate Institutional Expansion at the Intersection of Crypto, Finance, and AI
• Bybit Launches "Master Trader's Showtime: TradFi vs Crypto" Tournament With 200,000 USDT Prize Pool
• SentiPulse Launches SentiCat, Positioning Agents as the Foundation for Digital Humans
• Echosens Appoints Romain Baujard as Group Chief Executive Officer
• Duck Creek Kicks Off Formation '26 as Strong Fiscal Momentum Signals Accelerating Demand for its Intelligent Core Insurance Platform
• JCET Reports 42.7% YoY Surge in Q1 2026 Net Profit Attributable to Shareholders
• SINGAPORE INTERNATIONAL FESTIVAL OF ARTS 2026 SETS THE STAGE FOR "LET'S PLAY!"
• AXIA Time Expands Portfolio with Official Licensed Product of the FIFA World Cup 2026™